Science Applications International Corp Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
5.1%projected annual EPS growth
Analyst Coverage
10analysts covering
FY EPS (est.)
$10.18next fiscal year
Monitoring Framework
Key Performance Indicators
Adjusted EBITDA Margin Quarterly1,160.0%Target: 10.1% to 10.3% (Full Year FY27 Guidance)
Book-to-Bill Ratio Quarterly110.0%Target: >= 100x%
Free Cash Flow Quarterly118MTarget: > $600 Million (Full Year FY27 Guidance)
Watch Items
- Vanguard Recompete Transition to EVOLVETrigger: Task order awards under the $10 billion EVOLVE ceilingAction: Monitor win rates and incremental task order awards to derisk the $250 million Vanguard run-rate transition.
- Portfolio Realignment and Enterprise IT DivestituresTrigger: Execution of additions or subtractions to the portfolioAction: Evaluate the impact of shifting away from commoditized enterprise IT on organic revenue growth and margin expansion.
Research as of 19 Jun 2026